| Tinatin Gotsiridze, MD | |
|
730 Weiland Rd, Greece Dermatological Associates, Rochester, NY 14626-3919 | |
| (585) 719-9600 | |
| Not Available |
| Full Name | Tinatin Gotsiridze |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 15 Years |
| Location | 730 Weiland Rd, Rochester, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255566394 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 2684651 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Dermatology Of 19th Street Llc | 2567626567 | 7 |
News Archive
Two phase 3 trials, published in The Lancet, have shown that a novel oral drug called regorafenib could offer survival benefits to people with bowel (colorectal) cancer or gastrointestinal stromal tumour (GIST) following failure of existing treatments.
Preventable medical errors of various kinds kill at least 200,000 Americans each year, making this the third leading cause of death in the United States, six times as many deaths as from auto accidents. One way to reduce such errors is for consumers to choose the best surgeons. For the first time ever, consumers across the U.S. today have access to ratings of individual surgeons based on outcomes—how often their patients die in hospital or within 90 days of hospital discharge, have serious complications in hospital, or need to be readmitted to a hospital within 90 days of discharge.
Lexicon Pharmaceuticals, Inc. today announced that it has priced its offering of $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes due 2021 (the "Convertible Notes") in a private offering within the United States.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
› Verified 4 days ago
| Entity Name | Integrated Dermatology Of K Street Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053567206 PECOS PAC ID: 8729147889 Enrollment ID: O20081104000305 |
News Archive
Two phase 3 trials, published in The Lancet, have shown that a novel oral drug called regorafenib could offer survival benefits to people with bowel (colorectal) cancer or gastrointestinal stromal tumour (GIST) following failure of existing treatments.
Preventable medical errors of various kinds kill at least 200,000 Americans each year, making this the third leading cause of death in the United States, six times as many deaths as from auto accidents. One way to reduce such errors is for consumers to choose the best surgeons. For the first time ever, consumers across the U.S. today have access to ratings of individual surgeons based on outcomes—how often their patients die in hospital or within 90 days of hospital discharge, have serious complications in hospital, or need to be readmitted to a hospital within 90 days of discharge.
Lexicon Pharmaceuticals, Inc. today announced that it has priced its offering of $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes due 2021 (the "Convertible Notes") in a private offering within the United States.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
› Verified 4 days ago
| Entity Name | Integrated Dermatology Of 19th Street Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801166467 PECOS PAC ID: 2567626567 Enrollment ID: O20120601000481 |
News Archive
Two phase 3 trials, published in The Lancet, have shown that a novel oral drug called regorafenib could offer survival benefits to people with bowel (colorectal) cancer or gastrointestinal stromal tumour (GIST) following failure of existing treatments.
Preventable medical errors of various kinds kill at least 200,000 Americans each year, making this the third leading cause of death in the United States, six times as many deaths as from auto accidents. One way to reduce such errors is for consumers to choose the best surgeons. For the first time ever, consumers across the U.S. today have access to ratings of individual surgeons based on outcomes—how often their patients die in hospital or within 90 days of hospital discharge, have serious complications in hospital, or need to be readmitted to a hospital within 90 days of discharge.
Lexicon Pharmaceuticals, Inc. today announced that it has priced its offering of $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes due 2021 (the "Convertible Notes") in a private offering within the United States.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tinatin Gotsiridze, MD 730 Weiland Rd, Greece Dermatological Associates, Rochester, NY 14626-3919 Ph: (585) 719-9600 | Tinatin Gotsiridze, MD 730 Weiland Rd, Greece Dermatological Associates, Rochester, NY 14626-3919 Ph: (585) 719-9600 |
News Archive
Two phase 3 trials, published in The Lancet, have shown that a novel oral drug called regorafenib could offer survival benefits to people with bowel (colorectal) cancer or gastrointestinal stromal tumour (GIST) following failure of existing treatments.
Preventable medical errors of various kinds kill at least 200,000 Americans each year, making this the third leading cause of death in the United States, six times as many deaths as from auto accidents. One way to reduce such errors is for consumers to choose the best surgeons. For the first time ever, consumers across the U.S. today have access to ratings of individual surgeons based on outcomes—how often their patients die in hospital or within 90 days of hospital discharge, have serious complications in hospital, or need to be readmitted to a hospital within 90 days of discharge.
Lexicon Pharmaceuticals, Inc. today announced that it has priced its offering of $80,000,000 aggregate principal amount of 5.25% Convertible Senior Notes due 2021 (the "Convertible Notes") in a private offering within the United States.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
› Verified 4 days ago
Dr. Yana Veyberman Ignatovich, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 120 Erie Canal Dr, Rochester, NY 14626 Phone: 585-719-9600 | |
Dr. Walter S Brooks, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 730 Weiland Rd, Rochester, NY 14626 Phone: 585-719-9600 Fax: 585-719-9872 | |
Dr. Leena Mehta, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2211 Lyell Ave, Rochester, NY 14606 Phone: 585-429-5555 Fax: 585-429-6581 | |
Dr. Christopher Brent Yelverton, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 10 Hagen Dr Ste 300, Rochester, NY 14625 Phone: 585-922-9770 Fax: 585-922-9733 | |
Jonathan Matthew Soh, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 505 Beahan Rd, Rochester, NY 14624 Phone: 716-755-6647 Fax: 716-755-6648 | |
Dr. Lesley C Loss, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 100 White Spruce Blvd, Rochester, NY 14623 Phone: 585-272-0700 Fax: 585-272-8356 | |
Allison L Holm, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 30 N Union St, Suite 105, Rochester, NY 14607 Phone: 585-232-8940 Fax: 585-232-8687 |